Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Cassiopea SpA announces approval of delisting of its shares on SIX Swiss Exchange

eqs_en 
0 0 25.02.22
Cassiopea SpA announces approval of delisting of its shares on SIX Swiss Exchange
 

Cassiopea S.p.A. / Key word(s): Delisting
Cassiopea SpA announces approval of delisting of its shares on SIX Swiss Exchange

25.02.2022 / 07:00

Lainate, Italy - February 25, 2022: Cassiopea S.p.A. (SIX: SKIN), ('Cassiopea'), a specialty pharmaceutical company developing and preparing to commercialize prescription drugs with novel mechanisms of action (MOA) to address long-standing essential dermatological conditions, today announced that SIX Exchange Regulation has approved the delisting of its shares from the SIX Swiss Exchange with the last day of trading on March 4, 2022, and delisting day on March 7, 2022. 

About Cassiopea
Cassiopea is a specialty pharmaceutical company developing and commercializing prescription drugs with novel mechanisms of action to address long-standing and essential dermatological conditions, particularly acne, androgenetic alopecia (or AGA) and genital warts. Cassiopea is investing in innovation that is driving scientific advancement in areas that have been largely ignored for decades. The portfolio comprises four unencumbered clinical candidates, for which Cassiopea owns the worldwide rights. The Company's strategy is to leverage this expertise to optimize the commercial potential for its products with commercial partners. For further information on Cassiopea, please visit www.cassiopea.com.

Contact

Cassiopea SpA

Pierpaolo Guzzo, CEO 
Tel              +39 02 868 911 24 
E-mail        [email protected]


End of Media Release
Language: English
Company: Cassiopea S.p.A.
Via Cristoforo Colombo 1
20045 Lainate
Switzerland
E-mail: [email protected]
Internet: https://www.cassiopea.com/
ISIN: IT0005108359
Listed: SIX Swiss Exchange
EQS News ID: 1288305

 
End of News EQS News Service

1288305  25.02.2022 

fncls.ssp?fn=show_t_gif&application_id=1288305&application_name=news&site_id=sharewise

Cassiopea SpA Stock

€0.010
-


Show more
Like: 0
Share
eqs_en 
EQS Group is a leading international provider of regulatory technology in the fields of corporate compliance and investor relations. In working with EQS Group, thousands of companies worldwide inspire trust by fulfilling complex national and international disclosure obligations, minimizing risks and communicating transparently with stakeholders.




Legal notice

Comments

Not a member yet? Sign up for free!